Our leadership team

Our highly skilled team has a combined 80+ years of experience in development, adaptation of processes to large-scale bioreactor systems and manufacturing on a variety of AAV serotypes, including novel engineered capsids.

Combined 80+ years of experience

Our team has a demonstrated track record of achievement in viral vector manufacturing with multiple AAV serotypes and scales. We deeply understand regulatory requirements and are focused on innovation.

Eduard Ayuso
Chief Executive Officer
Vincent Zuliani
Head of Business Development
Goutham Kumar Ganjam
Head of Upstream Process Development
Florian Leseigneur
Head of Downstream Process Development
Marco Wachowius
Head of Analytical Development
Martin Rhiel
Head of Quality Assurance
Joe Cox
Business Development Manager, North America
To top